Edick Paul R

CIK 00015311788 companiesROCKVILLE, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001531178

Recent Transactions

50 trades

Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Appreciation Right
2024-01-31+500,000→ 500,000 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2024-01-31+1,500,000→ 3,788,064 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-08-09$2.38/sh+10,000→ 2,288,064 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2023-01-31+750,000→ 2,278,064 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-12-13$1.45/sh+20,000→ 1,528,064 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-05-12$1.40/sh+100,000→ 1,508,064 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2022-01-03+600,000→ 1,408,064 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-11-15$2.28/sh+20,000→ 33,430 total
Purchase
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-11-11$2.08/sh+200,000→ 808,064 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−200,000→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+13,430→ 13,430 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+98,252→ 98,252 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+197,231→ 197,231 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Common Stock
2021-10-05+410,833→ 608,064 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+200,000→ 200,000 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−668,065→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−69,822→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−400,000→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−13,430→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−197,231→ 410,833 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Common Stock
2021-10-05−410,833→ 0 total
Disposition to Issuer
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-10-05−98,252→ 0 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+668,065→ 668,065 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+69,822→ 69,822 total
Award
Xeris Biopharma Holdings, Inc.$XERS
Stock Option (Right to Buy)
2021-10-05+400,000→ 400,000 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
2021-01-29+400,000→ 400,000 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2021-01-29+225,000→ 636,134 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2020-12-09$4.06/sh+10,000→ 411,134 total
Award
Milestone Pharmaceuticals Inc.$MIST
Stock Option (right to buy)
2020-06-05+15,000→ 15,000 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2020-05-08$3.00/sh+33,000→ 401,134 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2020-02-14$4.15/sh+20,000→ 183,134 total
Tax Payment
XERIS PHARMACEUTICALS INC
Common Stock
2020-01-31$6.37/sh−9,801→ 163,134 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2020-01-31+185,000→ 368,134 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2019-11-25$8.55/sh+17,935→ 172,935 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2019-05-24+6,154→ 31,390 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2019-05-24−6,154→ 0 total
Purchase
XERIS PHARMACEUTICALS INC
Common Stock
2019-03-11$9.12/sh+30,000→ 155,000 total
Award
XERIS PHARMACEUTICALS INC
Stock Option (right to buy)
2019-01-31+200,000→ 200,000 total
Award
XERIS PHARMACEUTICALS INC
Common Stock
2019-01-31+125,000→ 125,000 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-08-23$10.44/sh+500→ 25,236 total
Conversion
XERIS PHARMACEUTICALS INC
Common Stock
2018-06-25+13,430→ 13,430 total
Conversion
XERIS PHARMACEUTICALS INC
Series C Preferred Stock
2018-06-25−23,922→ 0 total
Award
PDL BIOPHARMA, INC.
Common stock
2018-06-08$2.76/sh+54,348→ 214,563 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+1,591→ 24,736 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−4,050→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series A Preferred Shares
2018-05-30−15,913→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+4,050→ 23,145 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+15,913→ 19,095 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−1,591→ 0 total
Award
Iterum Therapeutics plc$ITRM
Restricted Stock Units
2018-05-24+6,154→ 6,154 total

Companies

Recent Filings

Address

805 KING FARM BLVD, SUITE 550

ROCKVILLE, MD, 20850

View on SEC.gov